动力旋转鞘与伸缩鞘在经静脉电极拔除中的比较及WARD-10评分
本回顾性研究纳入308例接受经静脉电极拔除的患者,其中73例使用非动力伸缩鞘,235例使用TightRail动力旋转鞘。尽管TightRail组电极年限更长、病情更复杂,两组的完全成功率、临床成功率及主要并发症率均无显著差异。研究开发了包含体重、年龄、入路、糖尿病和电极年限的WARD-10风险评分,用于个体化风险分层。
要点
- TightRail在更复杂病例中成功率与伸缩鞘相当,可作为一线选择。
- 主要并发症主要与患者及电极因素相关,而非单纯由拔除策略决定。
- WARD-10评分≥3分时敏感度72.7%、特异度85.5%,可用于术前风险告知。
核心结论
- TightRail在更复杂病例中优先使用,仍取得与伸缩鞘相当的疗效和手术效率。
- 主要并发症主要与患者和电极相关危险因素有关,而非单纯取决于拔除策略。
- WARD-10评分可为经静脉电极拔除提供简便的个体化风险分层工具。
研究设计与样本
- 单中心回顾性队列研究,纳入2014至2025年308例接受经静脉电极拔除的连续患者。
- 排除单纯牵拉拔除病例后,分为73例伸缩鞘组和235例TightRail组进行比较。
- 通过多因素logistic回归识别主要并发症预测因素,并开发WARD-10风险评分。
主要发现
- TightRail组最老电极年限显著高于伸缩鞘组(11.4±6.8年对7.0±5.3年,p<0.001)。
- 完全成功率在伸缩鞘组为91.8%,TightRail组为94.0%(p=0.586),临床成功率分别为93.2%和95.3%(p=0.545)。
- 总体手术时间和透视时间在两组间无显著差异,三组分析中TightRail单独使用组手术时间最短。
- 主要并发症率在伸缩鞘组为1.4%,TightRail组为4.3%(p=0.469),组间差异无统计学意义。
- 主要并发症多发生于电极年限≥10年的病例,电极年限<10年时无论采用何种策略并发症率均较低。
关键数值与推荐
- WARD-10评分包含:体重<60 kg、年龄≥74岁、右侧锁骨下入路、糖尿病、电极年限≥10年。
- 主要并发症独立预测因素为:体重<60 kg、右侧锁骨下入路、糖尿病和电极年限≥10年。
- WARD-10评分区分度良好(AUC 0.857),截断值≥3分时敏感度为72.7%,特异度为85.5%。
临床怎么用
- 对电极年限长或合并WARD-10高危因素的患者,应在具备外科应急条件的中心实施拔除。
- 术前可计算WARD-10评分进行风险分层,≥3分者需加强围术期监测和应急准备。
- TightRail可作为复杂经静脉电极拔除的有效选择,但策略选择应结合中心经验和患者风险因素。
局限性
- 单中心回顾性设计存在选择偏倚,TightRail组优先用于更复杂病例可能影响直接比较。
- 主要并发症为少见事件,样本量可能不足以检出策略间的显著差异。
- WARD-10评分基于本研究数据开发,缺乏外部验证队列确认其普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TightRail achieved high efficacy and efficient performance despite preferential use in more complex cases, and major complications were primarily associated with patient and lead-related risk factors rather than the extraction strategy alone. The WARD 10 score provides a simple tool for individualized risk stratification in TLE. ABSTRACT Background Transvenous lead extraction (TLE) is essential for CIED management and is generally safe with contemporary techniques, although rare cardiac or vascular complications can be life-threatening. Comparative data between non-powered telescoping sheaths (TS) and powered rotational sheaths remain limited. Methods After excluding simple traction cases, 308 consecutive TLE patients treated at a tertiary center (2014–2025) were analyzed (73 TS-only; 235 TightRail). Procedural success, efficiency, and complications were compared. Major complications were defined as life-threatening or fatal procedure-related events, or events requiring urgent invasive or surgical intervention. Predictors of major complications were identified using multivariable logistic regression, and a pragmatic risk score (WARD-10: Weight < 60 kg, Age ≥ 74 years, Right subclavian approach, Diabetes mellitus, lead age ≥ 10 years) was developed. Results The TightRail group included significantly older leads (oldest lead age 7.0 ± 5.3 vs. 11.4 ± 6.8 years, p < 0.001). Complete and clinical success were similar between TS-only and TightRail (91.8% vs. 94.0%, p = 0.586; 93.2% vs. 95.3%, p = 0.545), and overall procedure and fluoroscopy times did not differ significantly. In three-group analysis, TightRail-only demonstrated the shortest procedural duration. Major complication rates did not differ significantly between the TS-only and TightRail groups (1.4% vs. 4.3%, p = 0.469); these events predominantly occurred in leads ≥ 10 years, whereas complication rates were low regardless of extraction strategy in leads < 10 years. Independent predictors of major complications were weight < 60 kg, right subclavian approach, diabetes mellitus, and lead age ≥ 10 years. WARD-10 demonstrated good discrimination (AUC 0.857); a cutoff ≥ 3 yielded 72.7% sensitivity and 85.5% specificity. Conclusion TightRail achieved comparable efficacy and efficient performance despite preferential use in more complex cases. Major complications were primarily associated with patient- and lead-related risk factors rather than the extraction strategy alone. The WARD-10 score provides a simp
引用
- Journal of Cardiovascular Electrophysiology:Powered Rotational Sheaths in Complex Transvenous Lead Extraction: Comparative Outcomes With Telescoping Sheaths and the WARD‐10 Score
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。